DNA adducts in granulocytes of hospital workers exposed to ethylene oxide

American Journal of Industrial Medicine

Volumn 50, Issue 4, 2007, Pages 293-302

  Yong, Lee C ^a   Schulte, Paul A ^a   Kao, Chi Yu ^b   Giese, Roger W ^b   Boeniger, Mark F ^a   Strauss, Gary H S ^c   Petersen, Martin R ^a   Wiencke, John K ^d  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c Pb2Au Biomedical Technology Assessment and Development   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNA adducts; Ethylene oxide; Gas chromatography electron capture mass spectrometry; Granulocytes; Hospital workers; N7 (2 hydroxyethyl)guanine; Occupational exposure

Indexed keywords

7 (2 HYDROXYETHYL)GUANINE; CARCINOGEN; ETHYLENE OXIDE; GLUTATHIONE TRANSFERASE T1; INDUSTRIAL CHEMICAL;

ADULT; ARTICLE; BLOOD SAMPLING; CIGARETTE SMOKING; DEMOGRAPHY; DNA ADDUCT; FEMALE; GAS CHROMATOGRAPHY; GENOTYPE; GRANULOCYTE; HOSPITAL PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; OCCUPATIONAL EXPOSURE; STATISTICAL ANALYSIS;

ADULT; DNA ADDUCTS; ETHYLENE OXIDE; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENOTYPE; GRANULOCYTES; GUANINE; HUMANS; MALE; MEXICO; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PERSONNEL, HOSPITAL; PILOT PROJECTS; UNITED STATES;

EID: 34247194884     PISSN: 02713586     EISSN: 10970274     Source Type: Journal    
DOI: 10.1002/ajim.20443     Document Type: Article

References (41)

1. Bolt HM, Leutbecher M, Golka K. 1997. A note on the physiological background of the ethylene oxide adduct 7-(2-hydroxyethyl)guanine in DNA from human blood. Arch Toxicol 71:719-721.
2. Boogaard PJ. 2002. Use of haemoglobin adducts in exposure monitoring and risk assessment. J Chromatogr B Analyt Technol Biomed Life Sci 778(1-2):309-322.
3. Carrano AV, Moore DH. 1982. The rationale and methodology for quantifying sister chromatid exchange in humans. In: Heddle JA, editor. Mutagenicity: New horizons in genetic toxicology. New York, London: Academic Press. p 268-306.
4. Coggon D, Harris EC, Poole J, Palmer KT. 2004. Mortality of workers exposed to ethylene oxide: Extended follow up of a British cohort. Occup Environ Med 61:358-362.
5. Dellarco VL, Generoso WM, Sega GA, Fowle JR, III, Jacobson-Kram D. 1990. Review of the mutagenicity of ethylene oxide. Environ Mol Mutagen 16:85-103.
6. Elliott LJ, Ringenburg VL, Morelli-Schroth P, Halperin WE, Herrick RF. 1988. Ethylene oxide exposures in hospitals. Appl Ind Hyg 3(5):141-145.
7. Fang JL, Vaca CE. 1997. Detection of DNA adducts of acetaldehyde in peripheral white blood cells of alcohol abusers. Carcinogenesis 18(4):627-632.
8. Filser JG, Denk B, Tornqvist M, Kessler W, Ehrenberg L. 1992. Pharmacokinetics of ethylene in man: Body burden with ethylene oxide and hydroxyethylation of hemoglobin due to endogenous and environmental ethylene. Arch Toxicol 66:157-163.
9. Florack EIM, Zielhuis GA. 1990. Occupational ethylene oxide exposure and reproduction. Int Arch Occup Environ Health 62:273-277.
10. Fost U, Marczynski B, Kasemann R, Peter H. 1989. Determination of 7-(2-hydroxyethyl)guanine with gas chromatography/mass spectrometry as a parameter for genotoxicity of ethylene oxide. Arch Toxicol Suppl 13:250-253.
11. Generoso WM, Cain KT, Hughes LA, Sega GA, Braden PW, Gosslee DG, Shelby MD. 1986. Ethylene oxide dose and dose-rate effects in the mouse dominant-lethal test. Environ Mutagen 8:1-7.
12. Godschalk RWL, Maas LM, Van Zandwijk N, van't Veer LJ, Breedijk A, Borm PJA, Verhaert J, Kleinjans JCS, van Schooten FJ. 1998. Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers. Carcinogenesis 19(5):819-825.
13. Granath F, Rohlen O, Goransson C, Hansson L, Magnusson A, Tornqvist M. 1996. Relationship between dose in vivo of ethylene oxide and exposure to ethene studied in exposed workers. Human Exp Toxicol 15(10):826-833.
14. Hemminki K, Koskinen M, Rajaniemi H, Zhao C. 2000. DNA adducts, mutations, and cancer 2000. Regul Toxicol Pharmacol 32(3):264-275.
15. IARC. 1994. Ethylene oxide. IARC Monogr Eval Carcinog Risk Hum 60:73-159.
16. Kao C, Giese RW. 2005. Measurement of N7-(2′-Hydroxyethyl)guanine in human DNA by gas chromatography electron capture mass spectrometry. Chem Res Toxicol 18:70-75.
17. Kolman A, Chovanec M, Osterman-Golkar S. 2002. Gentoxic effects of ethylene oxide, propylene oxide and epichlorohydrin in humans: Update review (1990-2001). Mutat Res 512:173-194.
18. LaMontagne AD, Oakes JM, Lopez TRN. 2004. Long-term ethylene oxide exposure trends in US hospitals: Relationship with OSHA regulatory and enforcement actions. Am J Public Health 94(9):1614-1619.
19. Li F, Segal A, Solomon JJ. 1992. In vitro reaction of ethylene oxide with DNA and characterization of DNA adducts. Chem Biol Interact 83:35-54.
20. Miller EC, Miller JA. 1981. Mechanisms of chemical carcinogenesis. Cancer 47:1055-1064.
21. Mustonen R, Hemminki K. 1992. 7-Methylguanine levels in DNA of smokers' and non-smokers' total white blood cells, granulocytes and lymphocytes. Carcinogenesis 13:1951-1955.
22. Nestmann ER, Bryant DW, Carr CJ. 1996. Toxicological significance of DNA adducts: Summary of discussions with an expert panel. Regul Toxicol Pharmacol 24:9-18.
23. NTP. 2002. 10th report on carcinogens. Research Triangle Park, NC, US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program.
24. Phillips DH, Farmer PB, Beland FA, Nath RG, Poirier MC, Reddy MV, Turteltaub KW. 2000. Methods of DNA adduct determination and their application to testing compounds for genotoxicity. Environ Mol Mutagen 35(3):222-233.
25. Savela K, Hemminki K. 1991. DNA adducts in lymphocytes and granulocytes of smokers and nonsmokers detected by the 32P-postlabelling assay. Carcinogenesis 12(3):503-508.
26. Schulte PA, Boeniger M, Walker JT, Schober SE, Pereira MA, Gulati DK, Wojciechowski JP, Garza A, Froelich R, Strauss G, Halperin WE, Herrick R, Griffith J. 1992. Biologic markers in hospital workers exposed to low levels of ethylene oxide. Mutat Res 278:237-251.
27. Segerback D. 1983. Alkylation of DNA and hemoglobin in the mouse following exposure to ethene and ethene oxide. Chem Biol Interact 45: 139-151.
28. Segerback D. 1990. Reaction products in hemoglobin and DNA after in vitro treatment with ethylene oxide and N-(2-hydroxyethyl)nitrosurea. Carcinogenesis (Lond.) 11:307-312.
29. Steenland K, Stayner L, Deddens J. 2004. Mortality analyses in a cohort of 18 235 ethylene oxide exposed workers: Follow up extended from 1987 to 1998. Occup Environ Med 61(1):2-7.
30. Tornqvist M, Osterman-Golkar S, Kautiainen A, Jensen S, Farmer PB, Ehrenberg L. 1986. Tissue doses of ethylene oxide in cigarette smokers determined from adduct levels in hemoglobin. Carcinogenesis 7(9): 1519-1521.
31. Tornqvist M, Kautiainen A, Gatz RN, Ehrenberg L. 1988. Hemoglobin adducts in animals exposed to gasoline and diesel exhausts. 1. Alkenes. J Appl Toxicol 8(3):159-170.
32. Tornqvist M, Gustaffson B, Kautiainen A, Harms-Ringdahl M, Granath F, Ehrenberg L. 1989. Unsaturated lipids and intestinal bacteria as sources of endogenous production of ethene and ethylene oxide. Carcinogenesis 10:39-41.
33. van Sittert NJ, Boogaard PJ, Natarajan AT, Tates AD, Ehrenberg LG, Tornqvist MA. 2000. Formation of DNA adducts and induction of mutagenic effects in rats following 4 weeks inhalation exposure to ethylene oxide as a basis for cancer risk assessment. Mutat Res 447:27-48.
34. Vineis P, Perera F. 2000. DNA adducts as markers of exposure to carcinogen and risk of cancer. Int J Cancer 88:325-328.
35. Walker VE, Fennell TR, Upton PB, MacNeela JP, Swenberg JA. 1993. Molecular dosimetry of DNA and hemoglobin adducts in mice and rats exposed to ethylene oxide. Environ Health Perspect 99: 11-17.
36. Wiencke JK, Pemble S, Ketterer B, Kelsey KT. 1995. Gene deletion of glutathione S-transferase theta: Correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 4:253-259.
37. Wraith MJ, Watson WP, Eadsforth CV, van Sittert NJ, Tornqvist M, Wright AS. 1988. An immunoassay for monitoring human exposure to ethylene oxide. In: Bartsch H, Hemminki K, O'Neill IK, editors. Methods for detecting DNA damaging agents in humans. Applications in cancer epidemiology and prevention. Lyon: International Agency for Research on Cancer. p 271-274.
38. Wu KY, Scheller N, Ranasinghe A, Yen TY, Sangaiah R, Giese R, Swenberg JA. 1999. A gas chromatography/electron capture/negative chemical ionization high-resolution mass spectrometry method for analysis of endogenous and exogenous N7-(2-hydroxyethyl)guanine in rodents and its potential for human biological monitoring. Chem Res Toxicol 12(8):722-729.
39. Yong LC, Schulte PA, Wiencke JK, Boeniger MF, Connally LB, Walker JT, Whelan EA, Ward EM. 2001. Hemoglobin adducts and sister chromatid exchanges in hospital workers exposed to ethylene oxide: Effects of glutathione S-transferase T1 and M1 genotypes. Cancer Epidemiol Biomarkers Prev 10:539-550.
40. Zhao C, Hemminki K. 2002. The in vivo levels of DNA alkylation products in human lymphocytes are not age dependent: An assay of 7-methyl- and 7-(2-hydroxyethyl)-guanine DNA adducts. Carcinogenesis 23(2):307-310.
41. Zhao C, Tyndyk M, Eide I, Hemminki K. 1999. Endogenous and background DNA adducts by methylating and 2-hydroxyethylating agents. Mutat Res 424(1-2):117-125.